Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Teva targets $4 billion lupus market with laquinimod study
Mesenchymal stromal-cell transplants induce oligodendrocyte progenitor migration and remyelination in a chronic demyelination model.
Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders.
Chronic oligodendrogenesis and remyelination after spinal cord injury in mice and rats.
Cognitive impairment in multiple sclerosis: clinical, radiologic and pathologic insights.
Peli1 promotes microglia-mediated CNS inflammation by regulating Traf3 degradation.
Treatment experience, burden and unmet needs (TRIBUNE) in MS study: results from five European countries.
Utility of neuropsychological testing for guiding treatment decisions in paediatric multiple sclerosis.
Disease mechanisms in MS: A role for sodium channels in regulation of macrophage-mediated pathology in multiple sclerosis lesions.
Sub-millimeter imaging of brain-free water for rapid volume assessment in atrophic brains.
Features of neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies.
Maraviroc and JC virus-associated immune reconstitution inflammatory syndrome.
GeNeuro Announces the Launch of Phase IIb Proof-of-Concept Study with GNbAC1 in Multiple Sclerosis and Servier Equity Investment
Effect of Vitamin A Supplementation on fatigue and depression in Multiple Sclerosis patients: A Double-Blind Placebo-Controlled Clinical Trial.
ACTH gel in the treatment of multiple sclerosis exacerbation: a case study.
Long-term effects of fingolimod in multiple sclerosis: The randomized FREEDOMS extension trial.
The first 10 years with multiple sclerosis: The longitudinal course of daily functioning.
Axial 3D gradient-echo imaging for improved multiple sclerosis lesion detection in the cervical spinal cord at 3T.
Month of birth as a risk factor for multiple sclerosis: an update.
Periventricular venous density in multiple sclerosis is inversely associated with T2 lesion count: a 7 Tesla MRI study.
The HLA region in multiple sclerosis.
K(+) channel alterations in the progression of experimental autoimmune encephalomyelitis.
Assessment of malignancy risk in patients with multiple sclerosis treated with intramuscular interferon beta-1a: retrospective evaluation using a health insurance claims database and postmarketing surveillance data.
Comparison of Point Estimates and Average Thicknesses of Retinal Layers Measured Using Manual Optical Coherence Tomography Segmentation for Quantification of Retinal Neurodegeneration in Multiple Sclerosis.
A rare presentation of atypical demyelination: tumefactive multiple sclerosis causing Gerstmann's syndrome.
Pages
« first
‹ previous
…
269
270
271
272
273
274
275
276
277
…
next ›
last »